Tasly Pharmaceutical Group Co., Ltd (600535.SS)
CNY 14.7
(0.75%)
CNY 14.7
(0.75%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.22 Billion CNY | 12.98% |
| 2022 | 1.27 Billion CNY | -53.38% |
| 2021 | 2.73 Billion CNY | 85.6% |
| 2020 | 1.47 Billion CNY | -19.91% |
| 2019 | 1.83 Billion CNY | -5.47% |
| 2018 | 1.94 Billion CNY | 11.48% |
| 2017 | 1.74 Billion CNY | 18.99% |
| 2016 | 1.46 Billion CNY | -16.09% |
| 2015 | 1.74 Billion CNY | 2.23% |
| 2014 | 1.7 Billion CNY | 21.96% |
| 2013 | 1.4 Billion CNY | 49.76% |
| 2012 | 935.75 Million CNY | 26.13% |
| 2011 | 741.87 Million CNY | 38.51% |
| 2010 | 535.6 Million CNY | 36.94% |
| 2009 | 391.13 Million CNY | 23.37% |
| 2008 | 317.04 Million CNY | 48.43% |
| 2007 | 213.59 Million CNY | -18.64% |
| 2006 | 262.54 Million CNY | 13.4% |
| 2005 | 231.52 Million CNY | 6.73% |
| 2004 | 216.93 Million CNY | 22.0% |
| 2003 | 177.81 Million CNY | 21.04% |
| 2002 | 146.9 Million CNY | 12.7% |
| 2001 | 130.34 Million CNY | 30.81% |
| 2000 | 99.65 Million CNY | 13.97% |
| 1999 | 87.43 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 204.5 Million CNY | -60.09% |
| 2024 Q1 | 382.17 Million CNY | 203.91% |
| 2024 Q2 | 512.38 Million CNY | 34.07% |
| 2023 Q3 | 377.24 Million CNY | -14.55% |
| 2023 Q1 | 387.97 Million CNY | 258.84% |
| 2023 Q2 | 441.45 Million CNY | 13.78% |
| 2023 FY | 1.43 Billion CNY | 12.98% |
| 2023 Q4 | 125.75 Million CNY | -66.67% |
| 2022 Q2 | 120.76 Million CNY | -54.06% |
| 2022 FY | 1.27 Billion CNY | -53.38% |
| 2022 Q4 | 108.11 Million CNY | -78.64% |
| 2022 Q3 | 506.05 Million CNY | 319.02% |
| 2022 Q1 | 262.91 Million CNY | -74.61% |
| 2021 Q3 | 516.51 Million CNY | -35.52% |
| 2021 Q2 | 801.06 Million CNY | 110.77% |
| 2021 Q1 | 380.06 Million CNY | 5213.34% |
| 2021 FY | 2.73 Billion CNY | 85.6% |
| 2021 Q4 | 1.03 Billion CNY | 100.44% |
| 2020 Q1 | 366.77 Million CNY | 633.75% |
| 2020 Q3 | 576.76 Million CNY | 10.54% |
| 2020 Q4 | 7.15 Million CNY | -98.76% |
| 2020 Q2 | 521.77 Million CNY | 42.26% |
| 2020 FY | 1.47 Billion CNY | -19.91% |
| 2019 FY | 1.83 Billion CNY | -5.47% |
| 2019 Q3 | 305.24 Million CNY | -44.77% |
| 2019 Q4 | -68.71 Million CNY | -122.51% |
| 2019 Q1 | 548.97 Million CNY | 102.13% |
| 2019 Q2 | 552.71 Million CNY | 0.68% |
| 2018 Q4 | 271.59 Million CNY | -48.28% |
| 2018 FY | 1.94 Billion CNY | 11.48% |
| 2018 Q3 | 525.1 Million CNY | -24.16% |
| 2018 Q2 | 692.37 Million CNY | 51.93% |
| 2018 Q1 | 455.7 Million CNY | 17.51% |
| 2017 Q4 | 387.8 Million CNY | -12.69% |
| 2017 FY | 1.74 Billion CNY | 18.99% |
| 2017 Q3 | 444.15 Million CNY | -14.3% |
| 2017 Q1 | 394.26 Million CNY | 79.49% |
| 2017 Q2 | 518.28 Million CNY | 31.46% |
| 2016 Q1 | 330.81 Million CNY | 20.49% |
| 2016 FY | 1.46 Billion CNY | -16.09% |
| 2016 Q4 | 219.65 Million CNY | -44.38% |
| 2016 Q3 | 394.91 Million CNY | -24.17% |
| 2016 Q2 | 520.76 Million CNY | 57.42% |
| 2015 Q4 | 274.55 Million CNY | -43.92% |
| 2015 Q1 | 405.43 Million CNY | 65.59% |
| 2015 FY | 1.74 Billion CNY | 2.23% |
| 2015 Q2 | 577.63 Million CNY | 42.47% |
| 2015 Q3 | 489.61 Million CNY | -15.24% |
| 2014 Q3 | 478.73 Million CNY | -17.01% |
| 2014 Q2 | 576.83 Million CNY | 41.14% |
| 2014 FY | 1.7 Billion CNY | 21.96% |
| 2014 Q4 | 244.84 Million CNY | -48.86% |
| 2014 Q1 | 408.68 Million CNY | 35.3% |
| 2013 Q3 | 361.05 Million CNY | -24.76% |
| 2013 Q1 | 258.43 Million CNY | 28.87% |
| 2013 FY | 1.4 Billion CNY | 49.76% |
| 2013 Q4 | 302.05 Million CNY | -16.34% |
| 2013 Q2 | 479.85 Million CNY | 85.68% |
| 2012 FY | 935.75 Million CNY | 26.13% |
| 2012 Q4 | 200.54 Million CNY | -24.38% |
| 2012 Q2 | 306.89 Million CNY | 88.16% |
| 2012 Q1 | 163.09 Million CNY | 19.8% |
| 2012 Q3 | 265.21 Million CNY | -13.58% |
| 2011 Q1 | 190.08 Million CNY | 27.27% |
| 2011 FY | 741.87 Million CNY | 38.51% |
| 2011 Q2 | 224.9 Million CNY | 18.32% |
| 2011 Q4 | 136.14 Million CNY | -28.63% |
| 2011 Q3 | 190.74 Million CNY | -15.19% |
| 2010 Q2 | 150.05 Million CNY | 77.25% |
| 2010 Q3 | 151.53 Million CNY | 0.98% |
| 2010 Q4 | 149.35 Million CNY | -1.44% |
| 2010 FY | 535.6 Million CNY | 36.94% |
| 2010 Q1 | 84.65 Million CNY | -32.76% |
| 2009 Q3 | 101.36 Million CNY | 0.33% |
| 2009 FY | 391.13 Million CNY | 23.37% |
| 2009 Q4 | 125.9 Million CNY | 24.21% |
| 2009 Q2 | 101.02 Million CNY | 60.78% |
| 2009 Q1 | 62.83 Million CNY | -43.79% |
| 2008 Q4 | 111.78 Million CNY | 46.54% |
| 2008 Q1 | 52.36 Million CNY | -41.28% |
| 2008 FY | 317.04 Million CNY | 48.43% |
| 2008 Q2 | 76.6 Million CNY | 46.3% |
| 2008 Q3 | 76.28 Million CNY | -0.41% |
| 2007 FY | 213.59 Million CNY | -18.64% |
| 2007 Q2 | 61.03 Million CNY | 248.76% |
| 2007 Q1 | 17.5 Million CNY | -84.72% |
| 2007 Q3 | 45.89 Million CNY | -24.81% |
| 2007 Q4 | 89.17 Million CNY | 94.31% |
| 2006 Q3 | 51.59 Million CNY | -13.19% |
| 2006 Q4 | 114.52 Million CNY | 121.96% |
| 2006 Q1 | 36.98 Million CNY | -65.45% |
| 2006 FY | 262.54 Million CNY | 13.4% |
| 2006 Q2 | 59.43 Million CNY | 60.72% |
| 2005 FY | 231.52 Million CNY | 6.73% |
| 2005 Q1 | 29.06 Million CNY | -69.8% |
| 2005 Q4 | 107.03 Million CNY | 143.94% |
| 2005 Q3 | 43.87 Million CNY | -14.88% |
| 2005 Q2 | 51.55 Million CNY | 77.39% |
| 2004 Q1 | 26.44 Million CNY | -69.6% |
| 2004 Q3 | 52.34 Million CNY | 24.92% |
| 2004 Q4 | 96.23 Million CNY | 83.85% |
| 2004 FY | 216.93 Million CNY | 22.0% |
| 2004 Q2 | 41.9 Million CNY | 58.47% |
| 2003 FY | 177.81 Million CNY | 21.04% |
| 2003 Q4 | 86.99 Million CNY | 162.62% |
| 2003 Q3 | 33.12 Million CNY | -3.07% |
| 2003 Q1 | 23.51 Million CNY | -49.49% |
| 2003 Q2 | 34.17 Million CNY | 45.32% |
| 2002 Q1 | 23.35 Million CNY | 0.0% |
| 2002 Q2 | 41.14 Million CNY | 76.15% |
| 2002 FY | 146.9 Million CNY | 12.7% |
| 2002 Q3 | 35.84 Million CNY | -12.88% |
| 2002 Q4 | 46.55 Million CNY | 29.89% |
| 2001 FY | 130.34 Million CNY | 30.81% |
| 2000 FY | 99.65 Million CNY | 13.97% |
| 1999 FY | 87.43 Million CNY | 0.0% |